Assessment of irisin levels in patients with bipolar depression and unipolar depression

Erzin G., Yuksel R. N., USTA M. B., Topcuoglu C., Orsel S.

ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, vol.11, no.6, pp.583-586, 2020 (ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 11 Issue: 6
  • Publication Date: 2020
  • Doi Number: 10.4328/acam.20283
  • Journal Name: ANNALS OF CLINICAL AND ANALYTICAL MEDICINE
  • Journal Indexes: Emerging Sources Citation Index (ESCI)
  • Page Numbers: pp.583-586
  • Keywords: Irisin, Depression, Bipolar disorder, Myokine, Duration of illness, RATING-SCALE, DISORDER, MISDIAGNOSIS, BDNF, MOOD
  • Ondokuz Mayıs University Affiliated: Yes

Abstract

Aim: Irisin is a myokine and adipokine which has neural effects such as playing a role in neural proliferation. There are studies in the literature reporting that irisin could be associated with neurodegenerative processes. Therefore, in this study, we aimed to evaluate the irisin levels in patients with bipolar depression and major depressive disorder.